Opaleye Management Inc. 13D and 13G filings for Larimar Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-16 5:11 pm Purchase |
2025-04-09 | 13G | Larimar Therapeutics, Inc. LRMR |
Opaleye Management Inc. | 3,952,409 6.170% |
2,392,409 (+153.36%) |
Filing |
| 2023-01-20 7:09 pm Purchase |
2022-12-31 | 13G | Larimar Therapeutics, Inc. LRMR |
Opaleye Management Inc. | 1,560,000 3.610% |
616,298 (+65.31%) |
Filing |
| 2022-02-18 4:32 pm Purchase |
2022-02-15 | 13G | Larimar Therapeutics, Inc. LRMR |
Opaleye Management Inc. | 943,702 5.320% |
943,702 (New Position) |
Filing |